Primary study · included by 1 review
The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies.
Ahmadinezhad 2022 · Ahmadinezhad Mozhgan, Arshadi Maedeh, Hesari Elahe, et al. · Epidemiology and health · 2022
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Risk of bladder cancer With overweight (BMI = >25 kg/m2) vs Without overweight (BMI = >25 kg/m2) | RR 1.06 [0.98, 1.15] | 23 studies · 33697415 participants | Very low |
Risk of bladder cancer With obesity (BMI = >30 kg/m2) vs Without obesity (BMI = >30 kg/m2) | RR 1.03 [0.96, 1.12] | 23 studies · 29563710 participants | Very low |
Risk of bladder cancer With diabetes vs Without diabetes | RR 1.23 [1.16, 1.31] | 17 studies · 83699162 participants | Very low |
Relative risk of bladder cancer With Lynch syndrome vs Without Lynch syndrome | RR 7.48 [3.70, 15.13] | 4 studies · 6760 participants | Low |
Risk of bladder cancer With metabolic syndrome vs Without metabolic syndrome | RR 1.09 [1.02, 1.17] | 2 studies · 12934208 participants | Very low |
Risk of bladder cancer With ANCA-associated vasculitis vs Without ANCA-associated vasculitis | RR 3.84 [2.72, 5.42] | 5 studies | Moderate |
Also linked to PM40928380-P150-O1, which does not match a current question in this review.
1 including review in total.